[1] SCHRIEBER R, GAREIS H.Gelatine handbook:Theory and industrial practice[M].Hoboken:Wiley, 2007.
[2] RAGLE R L, SAWITZKE A D.Nutraceuticals in the management of osteoarthritis:A critical review[J].Drugs & Aging, 2012, 29(9):717-731.
[3] 景淑萍. 胶原蛋白的安全性及其保健功能[J].甘肃高师学报, 2009, 14(5):82-83;89.
JING S P.On the safety of collagen and its application functions in healthcare industry[J].Journal of Gansu Normal Colleges, 2009, 14(5):82-83;89.
[4] 钱善华. 天然关节软骨的摩擦行为研究[D].徐州:中国矿业大学, 2009.
QIAN S H.Study on friction behavior about natural articular cartialge[D].Xuzhou:China University of Mining and Technology, 2009.
[5] JAABAR I, MICHE A, WANHERDRICK K, et al.Composition and structure of human cartilage extracellular matrix:Unravelling changes during osteoarthrosis at the nanoscale[J].Osteoarthritis and Cartilage, 2021, 29:S198.
[6] AIGNER T, SÖDER S, GEBHARD P M, et al.Mechanisms of Disease:Role of chondrocytes in the pathogenesis of osteoarthritis:Structure, chaos and senescence[J].Nature Clinical Practice Rheumatology, 2007, 3(7):391-399.
[7] MURPHY C A, GARG A K, SILVA-CORREIA J, et al.The Meniscus in normal and osteoarthritic tissues:Facing the structure property challenges and current treatment trends[J].Annual Review of Biomedical Engineering, 2019, 21:495-521.
[8] KIM H A, LEE Y J, SEONG S C, et al.Apoptotic chondrocyte death in human osteoarthritis[J].The Journal of Rheumatology, 2000, 27(2):455-462.
[9] 王斌, 邢丹, 董圣杰, 等.中国膝骨关节炎流行病学和疾病负担的系统评价[J].中国循证医学杂志, 2018, 18(2):134-142.
WANG B, XING D, DONG S J, et al.Prevalence and disease burden of knee osteoarthritis in China:A systematic review[J].Chinese Journal of Evidence-Based Medicine, 2018, 18(2):134-142.
[10] MAIESE K.Picking a bone with WISP1 (CCN4):New strategies against degenerative joint disease[J].Journal of Translational Science, 2016, 1(3):83-85.
[11] LEONG D J, CHOUDHURY M, HIRSH D M, et al.Nutraceuticals:potential for chondroprotection and molecular targeting of osteoarthritis[J].International Journal of Molecular Sciences, 2013, 14(11):23 063-23 085.
[12] NEOGI T.The epidemiology and impact of pain in osteoarthritis[J].Osteoarthritis and Cartilage, 2013, 21(9):1 145-1 153.
[13] LITWIC A, EDWARDS M H, DENNISON E M, et al.Epidemiology and burden of osteoarthritis[J].British Medical Bulletin, 2013, 105:185-199.
[14] BERTHELOT G, JOHNSON S, NOIREZ P, et al.The age-performance relationship in the general population and strategies to delay age related decline in performance[J].Archives of Public Health, 2019, 77:51.
[15] SALMON J H, RAT A C, SELLAM J, et al.Economic impact of lower-limb osteoarthritis worldwide:A systematic review of cost-of-illness studies[J].Osteoarthritis and Cartilage, 2016, 24(9):1 500-1 508.
[16] MOBASHERI A.The future of osteoarthritis therapeutics:Emerging biological therapy[J].Current Rheumatology Reports, 2013, 15(12):1-9.
[17] 高宗强, 郭雄, 陈君长, 等.大骨节病、骨关节炎软骨细胞分泌IL-1β、TNF-α及透明质酸对其影响实验研究[J].陕西医学杂志, 2015, 44(7):774-778.
GAO Z Q, GUO X, CHEN J C, et al.The effect of hyluronic acid on the expression of IL-1β, TNF-α in chondrocytes of Kashin-beck disease and osteoarthritis cultured in vitro[J].Shaanxi Medical Journal, 2015, 44(7):774-778.
[18] MALEMUD C J.Anticytokine therapy for osteoarthritis:Evidence to date[J].Drugs & Aging, 2010, 27(2):95-115.
[19] GOLDRING M B.Anticytokine therapy for osteoarthritis[J].Expert Opinion on Biological Therapy, 2001, 1(5):817-829.
[20] ZHOU X R, YANG H J, GUAN F, et al.T-2 toxin alters the levels of collagen II and its regulatory enzymes MMPs/TIMP-1 in a low-selenium rat model of kashin-beck disease[J].Biological Trace Element Research, 2016, 169(2):237-246.
[21] TONG T, ZHAO W, WU Y Q, et al.Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis[J].Inflammation Research, 2010, 59(5):369-377.
[22] PRIETO-ALHAMBRA D, JUDGE A, JAVAID M K, et al.Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis:Influences of age, gender and osteoarthritis affecting other joints[J].Annals of the Rheumatic Diseases, 2014, 73(9):1 659-1 664.
[23] GAO S G, ZENG C, LI L J, et al.Correlation between senescence-associated beta-galactosidase expression in articular cartilage and disease severity of patients with knee osteoarthritis[J].International Journal of Rheumatic Diseases, 2016, 19(3):226-232.
[24] JEON O H, KIM C, LABERGE R M,et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment[J]. Nature Medicine, 2017,23(6): 775-781.
[25] CHILDS B G, GLUSCEVIC M, BAKER D J, et al.Senescent cells:An emerging target for diseases of ageing[J].Nature Reviews Drug Discovery, 2017, 16(10):718-735.
[26] XU M, BRADLEY E W, WEIVODA M M, et al.Transplanted senescent cells induce an osteoarthritis-like condition in mice[J].The Journals of Gerontology:Series A, 2016, 72(6):780-785.
[27] SHEN X H, CUI Y.Progress in traditional Chinese and Western medicine treatments and nursing care of knee osteoarthritis[J].Chinese Nursing Research, 2015, 2(2-3):71-74.
[28] DEHGHAN M, SAFFARI M, RAFIEIAN-KOPAEI M, et al.Comparison of the effect of topical Hedera helix L.extract gel to diclofenac gel in the treatment of knee osteoarthritis[J].Journal of Herbal Medicine, 2020, 22:100350.
[29] UNGPRASERT P, CHEUNGPASITPORN W, CROWSON C S, et al.Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury:A systematic review and meta-analysis of observational studies[J].European Journal of Internal Medicine, 2015, 26(4):285-291.
[30] CATELLA-LAWSON F, REILLY M P, KAPOOR S C, et al.Cyclooxygenase inhibitors and the antiplatelet effects of aspirin[J].The New England Journal of Medicine, 2001, 345(25):1 809-1 817.
[31] UEBELHART D.Clinical review of chondroitin sulfate in osteoarthritis[J].Osteoarthritis and Cartilage, 2008, 16:S19-S21.
[32] LIU Q, WANG J F, SUN Y J, et al.Chondroitin sulfate from sturgeon bone protects chondrocytes via inhibiting apoptosis in osteoarthritis[J].International Journal of Biological Macromolecules, 2019, 134:1 113-1 119.
[33] DEAL C L, MOSKOWITZ R W.Nutraceuticals as therapeutic agents in osteoarthritis.The role of glucosamine, chondroitin sulfate, and collagen hydrolysate[J].Rheum Dis Clin North Am, 1999, 25(2):379-395.
[34] HOUPT J B, MCMILLAN R, WEIN C, et al.Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee[J].The Journal of Rheumatology, 1999, 26(11):2 423-2 430.
[35] WANDEL S, JÜNI P, TENDAL B, et al.Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee:Network meta-analysis[J].BMJ (Clinical Research Ed.), 2010, 341:c4675.
[36] GARZON C, MIHAILOVIC A, JIAN-YU E, et al.Evaluation of away-from-home excursion patterns after falling among individuals with glaucoma:A longitudinal study[J].BMC Geriatrics, 2022, 22(1):101.
[37] ADAM M.Therapie der osteoarthrose-welche wirkung haben gelantinepraparate? [J].Therapiewoche, 1991, 41.
[38] NAGLER-ANDERSON C, BOBER L A, ROBINSON M E, et al.Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen[J].Evidence-Based Complementary and Alternative Medicine, 1986, 83(19):7 443-7 446.
[39] DI CESARE MANNELLI L, MICHELI L, ZANARDELLI M, et al.Low dose native type II collagen prevents pain in a rat osteoarthritis model[J].BMC Musculoskeletal Disorders, 2013, 14:228.
[40] ASNAGLI H, MARTIRE D, BELMONTE N, et al.Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis[J].Arthritis Research & Therapy, 2014, 16(3):R115.
[41] LEÓN-LÓPEZ A, MORALES-PEÑALOZA A, MARTÍNEZ-JUÁREZ V M, et al.Hydrolyzed collagen-sources and applications[J].Molecules (Basel, Switzerland), 2019, 24(22):E4031.
[42] BELLO A E, OESSER S.Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders:A review of the literature[J].Current Medical Research and Opinion, 2006, 22(11):2 221-2 232.
[43] OESSER S, ADAM M, BABEL W, et al.Oral administration of 14C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL)[J].The Journal of Nutrition, 1999, 129(10):1 891-1 895.
[44] WANG L, WANG Q, QIAN J, et al.Bioavailability and bioavailable forms of collagen after oral administration to rats[J].J Agric Food Chem, 2015, 63(14):3 752-3 756.
[45] SHIGEMURA Y, KUBOMURA D, SATO Y, et al.Dose-dependent changes in the levels of free and peptide forms of hydroxyproline in human plasma after collagen hydrolysate ingestion[J].Food Chemistry, 2014, 159:328-332.
[46] ICHIKAWA S, MORIFUJI M, OHARA H, et al.Hydroxyproline-containing dipeptides and tripeptides quantified at high concentration in human blood after oral administration of gelatin hydrolysate[J].International Journal of Food Sciences and Nutrition, 2010, 61(1):52-60.
[47] SKOV K, OXFELDT M, THGERSEN R, et al.Enzymatic hydrolysis of a collagen hydrolysate enhances postprandial absorption rate:A randomized controlled trial[J].Nutrients, 2019, 11(5):E1064.
[48] GAUZA-WODARCZYK M, KUBISZ L, WODARCZYK D.Amino acid composition in determination of collagen origin and assessment of physical factors effects[J].International Journal of Biological Macromolecules, 2017, 104:987-991.
[49] LI Y S, XIAO W F, LUO W, et al.Alterations of amino acid metabolism in osteoarthritis:Its implications for nutrition and health[J].Amino Acids, 2016, 48(4):907-914.
[50] OESSER S, SEIFERT J.Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen[J].Cell and Tissue Research, 2003, 311(3):393-399.
[51] SCHUNCK M, SCHULZE C H, OESSER S.p199 disparate efficacy of collagen hydrolysate and glucosamine on the extracellular matrix metabolism of articular chondrocytes[J].Osteoarthritis and Cartilage, 2006, 14:S114.
[52] DAR Q A, SCHOTT E M, CATHELINE S E, et al.Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis[J].PLoS One, 2017, 12(4):e0174705.
[53] BROERE F, WIETEN L, KLEIN KOERKAMP E I, et al.Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes[J].Journal of Immunology, 2008, 181(2):899-906.
[54] PAUL C, LESER S, OESSER S.Significant amounts of functional collagen peptides can be incorporated in the diet while maintaining indispensable amino acid balance[J].Nutrients, 2019, 11(5):E1079.
[55] LIAN C, WANG X, QIU X, et al.Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1-SMAD1 interaction[J].Bone Research, 2019, 7:8.
[56] 张慧琴, 霍乃蕊, 冀霞, 等.羊骨胶原肽对大鼠腹腔巨噬细胞免疫能力的影响[J].中国实验动物学报, 2021, 29(2):176-182.
ZHANG H Q, HUO N R, JI X, et al.Effect of sheep bone collagen peptide on immune function in rat peritoneal macrophages[J].Acta Laboratorium Animalis Scientia Sinica, 2021, 29(2):176-182.
[57] VAN DER KRAAN P M, VAN DEN BERG W B.Chondrocyte hypertrophy and osteoarthritis:Role in initiation and progression of cartilage degeneration? [J].Osteoarthritis and Cartilage, 2012, 20(3):223-232.
[58] CUI Z, CRANE J, XIE H, et al.Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone[J].Annls of the Rhenmatic Diseases, 2016, 75(9):1 714-1 721.
[59] VAN DE WATER E, OOSTERLINCK M, DUMOULIN M, et al.The preventive effects of two nutraceuticals on experimentally induced acute synovitis[J].Equine Veterinary Journal, 2017, 49(4):532-538.
[60] ISAKA S, SOMEYA A, NAKAMURA S, et al.Evaluation of the effect of oral administration of collagen peptides on an experimental rat osteoarthritis model[J].Pharmaceutics, 2017, 13(6):2 699-2 706.
[61] MA C C, YU M X, HUANG Z J, et al.Oral administration of hydrolysates of cartilage extract in the prevention of osteoarthritis[J].Journal of Functional Foods, 2021, 78:104376.
